Systematic review on the use of adalimumab in autoinmune. Efficacy and safety in 54 patients

Statistics

Revisión sistemática del uso de adalimumab en enfermedades autoinmunes. Eficacia y seguridad en 54 pacientes

Cándido Díaz-Lagaresa, Rafael Belenguerb, Manuel Ramos-Casalsa,

Corresponding author

mramos@clinic.ub.es

Corresponding author.

a Laboratorio de Enfermedades Autoinmunes Josep Font, Servicio de Enfermedades Autoinmunes, IDIBAPS, Hospital Clinic, Barcelona, Spain

b Unidad de Reumatología, Hospital 9 d’Octubre, Valencia, Spain

Read

6014

Times
was read the article

2833

Total PDF

3181

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/S2173-5743(10)70029-0

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	31	64	95
2024 October	20	43	63
2024 September	22	18	40
2024 August	36	38	74
2024 July	26	35	61
2024 June	32	29	61
2024 May	40	34	74
2024 April	29	17	46
2024 March	34	37	71
2024 February	19	26	45
2024 January	25	27	52
2023 December	30	31	61
2023 November	22	23	45
2023 October	34	50	84
2023 September	39	41	80
2023 August	25	12	37
2023 July	25	28	53
2023 June	29	24	53
2023 May	21	17	38
2023 April	28	10	38
2023 March	37	31	68
2023 February	26	31	57
2023 January	23	20	43
2022 December	24	30	54
2022 November	26	26	52
2022 October	29	35	64
2022 September	17	37	54
2022 August	22	44	66
2022 July	29	43	72
2022 June	24	36	60
2022 May	34	49	83
2022 April	40	51	91
2022 March	34	42	76
2022 February	54	45	99
2022 January	30	42	72
2021 December	27	39	66
2021 November	33	50	83
2021 October	43	57	100
2021 September	37	57	94
2021 August	32	51	83
2021 July	32	38	70
2021 June	26	58	84
2021 May	32	46	78
2021 April	69	58	127
2021 March	70	38	108
2021 February	76	29	105
2021 January	53	29	82
2020 December	33	22	55
2020 November	19	21	40
2020 October	18	16	34
2020 September	29	22	51
2020 August	19	12	31
2020 July	15	11	26
2020 June	29	16	45
2020 May	39	22	61
2020 April	30	18	48
2020 March	10	10	20
2020 February	1	0	1
2020 January	2	0	2
2019 September	4	0	4
2019 June	2	0	2
2019 March	2	0	2
2019 January	1	0	1
2018 May	5	1	6
2018 April	15	9	24
2018 March	11	12	23
2018 February	11	2	13
2018 January	8	9	17
2017 December	8	4	12
2017 November	5	17	22
2017 October	7	5	12
2017 September	13	6	19
2017 August	8	8	16
2017 July	8	11	19
2017 June	20	6	26
2017 May	16	15	31
2017 April	13	6	19
2017 March	8	21	29
2017 February	6	3	9
2017 January	10	4	14
2016 December	34	14	48
2016 November	14	2	16
2016 October	27	11	38
2016 September	28	8	36
2016 August	17	3	20
2016 July	16	5	21
2016 June	0	7	7
2016 April	0	12	12
2016 March	1	4	5
2016 January	3	16	19
2015 December	3	0	3
2015 November	0	5	5
2015 October	3	9	12
2015 September	2	0	2
2015 August	1	0	1
2015 July	19	5	24
2015 June	23	16	39
2015 May	61	23	84
2015 April	50	23	73
2015 March	33	17	50
2015 February	19	22	41
2015 January	11	30	41
2014 December	24	26	50
2014 November	14	25	39
2014 October	17	26	43
2014 September	20	18	38
2014 August	25	26	51
2014 July	38	20	58
2014 June	49	18	67
2014 May	24	29	53
2014 April	39	19	58
2014 March	40	33	73
2014 February	32	21	53
2014 January	31	23	54
2013 December	25	14	39
2013 November	29	11	40
2013 October	32	22	54
2013 September	34	18	52
2013 August	22	13	35
2013 July	44	31	75
2013 June	32	22	54
2013 May	35	20	55
2013 April	25	28	53
2013 March	21	22	43
2013 February	20	26	46
2013 January	15	15	30
2012 December	23	13	36
2012 November	15	16	31
2012 October	9	17	26
2012 September	12	4	16
2012 July	1	0	1
2012 June	1	0	1
2012 May	3	0	3
2012 April	4	0	4
2012 March	2	0	2
2012 February	2	0	2
2012 January	3	0	3
2011 December	3	0	3
2011 October	4	0	4
2011 August	2	0	2
2011 July	1	0	1
2011 June	2	0	2
2011 May	3	0	3
2011 April	4	0	4
2011 March	5	0	5
2011 February	2	0	2
2011 January	9	0	9
2010 December	9	0	9
2010 November	19	0	19
2010 October	15	0	15
2010 September	5	0	5

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter